Back to stocks
ZBIO

ZBIO

Zenas BioPharma, Inc.• Healthcare

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
23
Partial Q3 2026
Total 13F value
$2.9M
Filed positions so far
New positions
5
This quarter
Sold positions
1
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Ia Global Asset Management Inc.

$1.5M54.8K0.02%-74.5%

Profund Advisors Llc

$431K16.0K0.01%-15.2%

Creative Planning

$422K15.7K0.00%+33.5%

China Universal Asset Management Co., Ltd.

$318K11.9K0.02%-36.9%

Mirae Asset Global Investments Co., Ltd.

$90K3.3K0.00%+17.9%

Gf Fund Management Co. Ltd.

$33K1.2K0.00%+8.7%

Sterling Capital Management Llc

$32K1.2K0.00%+1090.0%

Signaturefd, Llc

$32K1.2K0.00%+3.0%

Caitong International Asset Management Co., Ltd

$30K1.1K0.00%+54800.0%

Nisa Investment Advisors, Llc

$19K7100.00%+9.1%

Gamma Investing Llc

$8K2970.00%+52.3%

Torren Management, Llc

$3K950.00%Unchanged

Ifs Advisors, Llc

$2K750.00%New Position

Physician Wealth Advisors, Inc.

$2K670.00%Unchanged

Financial Consulate, Inc

$2K630.00%New Position

Parkside Financial Bank & Trust

$1K400.00%New Position

Fortitude Family Office, Llc

$782290.00%Unchanged

Corecap Advisors, Llc

$324120.00%Unchanged

Sjs Investment Consulting Inc.

$8130.00%New Position

Essential Partners Llc

$5420.00%Unchanged

Hughes Financial Services, Llc

$2910.00%Unchanged

Farther Finance Advisors, Llc

$2710.00%New Position

Covestor Ltd

$0130.00%-40.9%

Explore